Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nadia F Nocera

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Eplasty|March 5, 2013
Subungual melanoma of the thumbNadia F Nocera, Michael I Baruch, Minbae Kim
Eplasty|September 12, 2014
Cat bite cellulitisNadia F Nocera, Kunj K Desai, Mark S Granick
Future Oncology (London, England)|August 3, 2017
Boosting anti-HER2 CD4 T-helper responses in HER2 expressing ductal carcinoma in situNadia F Nocera, M Catherine Lee, Brian J Czerniecki
Immunotherapy|September 9, 2016
Restoring anti-oncodriver Th1 responses with dendritic cell vaccines in HER2/neu-positive breast cancer: progress and potentialLucy M De La Cruz, Nadia F Nocera, Brian J Czerniecki
Frontiers in Pharmacology|October 22, 2016
Restoring Lost Anti-HER-2 Th1 Immunity in Breast Cancer: A Crucial Role for Th1 Cytokines in Therapy and PreventionNadia F Nocera, M Catherine Lee, Lucy M De La Cruz, et al.
Journal of Surgical Education|April 2, 2018
NSQIP Analysis of Axillary Lymph Node Dissection Rates for Breast Cancer: Implications for Resident and Fellow ParticipationNadia F Nocera, Bryan J Pyfer, Lucy M De La Cruz, et al.
Annals of Surgical Oncology|November 10, 2016
Anti-HER2 CD4<sup>+</sup> T-Helper Type 1 Immune Response is Superior to Breast MRI for Assessing Response to Neoadjuvant Therapy in Patients with HER2-Positive Breast CancerLucy M De La Cruz, Elizabeth S McDonald, R Mick, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Eplasty|March 5, 2013
Subungual melanoma of the thumbNadia F Nocera, Michael I Baruch, Minbae Kim
Eplasty|September 12, 2014
Cat bite cellulitisNadia F Nocera, Kunj K Desai, Mark S Granick
Future Oncology (London, England)|August 3, 2017
Boosting anti-HER2 CD4 T-helper responses in HER2 expressing ductal carcinoma in situNadia F Nocera, M Catherine Lee, Brian J Czerniecki
Immunotherapy|September 9, 2016
Restoring anti-oncodriver Th1 responses with dendritic cell vaccines in HER2/neu-positive breast cancer: progress and potentialLucy M De La Cruz, Nadia F Nocera, Brian J Czerniecki
Frontiers in Pharmacology|October 22, 2016
Restoring Lost Anti-HER-2 Th1 Immunity in Breast Cancer: A Crucial Role for Th1 Cytokines in Therapy and PreventionNadia F Nocera, M Catherine Lee, Lucy M De La Cruz, et al.
Journal of Surgical Education|April 2, 2018
NSQIP Analysis of Axillary Lymph Node Dissection Rates for Breast Cancer: Implications for Resident and Fellow ParticipationNadia F Nocera, Bryan J Pyfer, Lucy M De La Cruz, et al.
Annals of Surgical Oncology|November 10, 2016
Anti-HER2 CD4<sup>+</sup> T-Helper Type 1 Immune Response is Superior to Breast MRI for Assessing Response to Neoadjuvant Therapy in Patients with HER2-Positive Breast CancerLucy M De La Cruz, Elizabeth S McDonald, R Mick, et al.
Pageof 1